[HTML][HTML] Evaluation of the long-term impact on quality after the end of pharmacist-driven warfarin therapy management in patients with poor quality of anticoagulation …
LR Marcatto, L Sacilotto, LC Tavares… - Frontiers in …, 2020 - frontiersin.org
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation …
LR Marcatto, L Sacilotto, LC Tavares… - FRONTIERS IN …, 2020 - bv.fapesp.br
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation …
LR Marcatto, L Sacilotto, LC Tavares… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation …
LR Marcatto, L Sacilotto, LC Tavares… - Frontiers in …, 2020 - europepmc.org
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
[引用][C] Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of …
LR Marcatto, L Sacilotto, LC Tavares… - Frontiers in …, 2020 - repositorio.usp.br
ReP USP - Detalhe do registro: Evaluation of the Long-Term Impact on Quality After the End
of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of …
of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of …
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation …
LR Marcatto, L Sacilotto, LC Tavares… - Frontiers in …, 2020 - research.monash.edu
Background: Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation …
LR MARCATTO, L SACILOTTO… - Frontiers in …, 2020 - observatorio.fm.usp.br
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
[HTML][HTML] Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of …
LR Marcatto, L Sacilotto, LC Tavares… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation …
LR Marcatto, L Sacilotto, LC Tavares… - FRONTIERS IN …, 2020 - bv.fapesp.br
Background Warfarin is the most common oral anticoagulant drug, especially in low-income
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
[PDF][PDF] Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of …
LR Marcatto, L Sacilotto, LC Tavares… - … . 11: 1056. doi …, 2020 - observatorio.fm.usp.br
Background: Warfarin is the most common oral anticoagulant drug, especially in lowincome
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …
and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or …